Academia.eduAcademia.edu

William House Cochlear Implant Study Group

2008, Otology & Neurotology

Abstract

During the past three decades, unilateral cochlear implantation (CI) has been established as an accepted medical treatment for selected individuals with advanced degrees of sensorineural hearing loss. More recently, a growing number of patients have received bilateral CI, and a developing body of literature has demonstrated a significant additional benefit from 2 implants. In turn, this has generated increasing public interest in bilateral CI. Naturally, third-party payers and governmental agencies have sought evidence to justify bilateral CI. In response, the William House Cochlear Implant Study Group (CISG) critically examined putative additional benefits of bilateral implantation.